HIV vaccine trial in Africa halted after disappointing initial results
African-led trial ended a year early as researchers conclude there is ‘little or no chance’ new combination vaccines cut HIV riskThefirst trial in Africa of two combination vaccines to prevent HIV has been halted after researchers concluded it was not working.The pre-exposure prophylaxis vaccine (PrEPVacc) was being tested on 1,500 people aged between 18 and 40 in Uganda, Tanzania and South Africa.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Samuel Okiror in Kampala Tags: Global development Aids and HIV Society Global health Uganda Tanzania South Africa Vaccines and immunisation World news Medical research Science Source Type: news
More News: African Health | AIDS Vaccine | HIV AIDS | Research | Science | South Africa Health | Tanzania Health | Uganda Health | Vaccines